Joel Verter, Ph.D. is a member of the American Statistical Association, the International Biometric Society, and the Society for Clinical Trials (Secretary and Executive Board Member, 1995-2003).
From July 1967 through January 1991, he served in the United States Public Health Service as a Commissioned Officer. He was assigned to the Biometrics Research Branch of the National Heart, Lung, and Blood Institute (NHLBI) where he served two terms as the acting Branch Chief (1982-1983, 1989-1990). During his tenure at the NHLBI, he contributed to the design, monitoring, and/or analysis of: the Framingham Heart Study; the Cooperative Study of Sickle Cell Disease; the Aspirin Myocardial Infarction Study (AMIS); the Multiple Risk Factor Intervention Trial (MRFIT); the Studies of Left Ventricular Disease (SOLVD); the Digitalis Trial; the Post-menopausal Estrogen Progestin Interventions (PEPI) trial; the Bypass Angioplasty Revascularization Intervention (BARI) trial; the Cardiac Arrhythmia Suppression (CAST) trial; the Granulocyte Transfusion trial; the Prophylactic Penicillin (PROPS) trials.
During his tenure at the George Washington University Biostatistics Center (1992-2002), he was the Principal Investigator of the Coordinating Center for two studies funded by the National Heart, Lung, and Blood Institute (PEACE and WAVE) and the Co-Principal Investigator for the Neonatal Intensive Care Units Research Network funded by the National Institute of Child and Human Development.
He is, or has been, a member of the Data and Safety Monitoring Boards for a number of NIH and industry sponsored multicenter clinical trials. He served a four-year term on the FDA Blood Products Advisory Committee (1995-1999) and has been a member of several ad hoc FDA advisory panels.
His major areas of research are in the fields of clinical trial design, monitoring, and analysis. Publications on which he has contributed have appeared in many medical journals, including the New England Journal of Medicine, JAMA, Circulation, Journal of Pediatrics, as well as Statistics in Medicine.
He received his B.S. in Mathematics from the City College of New York (1965) and his Ph.D. from the University of North Carolina (1979).